Dogwood Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Gregory Duncan, with a market cap of $66.1M.
Upcoming earnings announcement for Dogwood Therapeutics
Past 6 earnings reports for Dogwood Therapeutics
We use cookies for analytics. See our Privacy and Cookie Policy.